Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups

被引：2
|
作者：
Huang, Qiao [1 ]
Quan, Baoxue [2 ,3 ]
Chen, Yan [2 ,3 ]
Zhao, Xiu [2 ,3 ]
Zhou, Yanmei [2 ,3 ]
Huang, Chong [2 ,3 ]
Qiao, Jingxin [2 ,3 ]
Wang, Yifei [2 ,3 ]
Li, Yueyue [2 ,3 ]
Yang, Shengyong [2 ,3 ,4 ]
Lei, Jian [2 ,3 ,5 ]
Li, Linli [1 ]
机构：
[1] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[4] Frontier Med Ctr, Tianfu Jincheng Lab, Chengdu 610212, Sichuan, Peoples R China
[5] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu 610041, Sichuan, Peoples R China
来源：
BIOORGANIC CHEMISTRY | 2024年 / 143卷
基金：
中国国家自然科学基金;
关键词：
SARS-CoV-2; Main protease; Covalent inhibitor; Protein structure; POTENT;
D O I：
10.1016/j.bioorg.2023.107001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Although the SARS-CoV-2 pandemic has ended, multiple sporadic cases still exist, posing a request for more antivirals. The main protease (Mpro) of SARS-CoV-2, a key enzyme for viral replication, is an attractive target for drug development. Here, we report the discovery of a new potent alpha-ketoamide-containing Mpro inhibitor, N-((R)1-cyclohexyl-2-(((R)-3-methoxy-1-oxo-1-((1-(2-oxo-2-((thiazol-2-ylmethyl)amino)acetyl)cyclobutyl)amino) propan-2-yl)amino)-2-oxoethyl)-4,4-difluorocyclohexane-1-carboxamide (20j). This compound presented promising enzymatic inhibitory activity against SARS-CoV-2 Mpro with an IC50 value of 19.0 nM, and an excellent antiviral activity in cell-based assay with an EC50 value of 138.1 nM. This novel covalent inhibitor may be used as a lead compound for subsequent drug discovery against SARS-CoV-2.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Biochemical screening for SARS-CoV-2 main protease inhibitors
    Coelho, Camila
    Gallo, Gloria
    Campos, Claudia B.
    Hardy, Leon
    Wurtele, Martin
    PLOS ONE, 2020, 15 (10):
  • [22] Protein-ligand interactions from a quantum fragmentation perspective: The case of the SARS-CoV-2 main protease interacting with α-ketoamide inhibitors
    Genovese, Luigi
    Dawson, William
    Nakajima, Takahito
    Cristiglio, Viviana
    Vallet, Valerie
    Masella, Michel
    JOURNAL OF CHEMICAL PHYSICS, 2023, 158 (21):
  • [23] Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
    Hung, Hui-Chen
    Ke, Yi-Yu
    Huang, Sheng Yu
    Huang, Peng-Nien
    Kung, Yu-An
    Chang, Teng-Yuan
    Yen, Kuei-Jung
    Peng, Tzu-Ting
    Chang, Shao-En
    Huang, Chin-Ting
    Tsai, Ya-Ru
    Wu, Szu-Huei
    Lee, Shiow-Ju
    Lin, Jiunn-Horng
    Liu, Bing-Sin
    Sung, Wang-Chou
    Shih, Shin-Ru
    Chen, Chiung-Tong
    Hsu, John Tsu-An
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [24] Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2
    Silva, Jose Rogerio A.
    Kruger, Hendrik G.
    Molfetta, Fabio A.
    RSC ADVANCES, 2021, 11 (38) : 23450 - 23458
  • [25] In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
    Gao, Menghan
    Kang, Dongwei
    Liu, Na
    Liu, Yanna
    MOLECULES, 2023, 28 (14):
  • [26] Discovery of benzodiazepine derivatives as a new class of covalent inhibitors of SARS-CoV-2 main protease
    Wang, Falu
    Zeng, Rui
    Qiao, Jingxin
    Xia, Anjie
    Li, Yueshan
    Li, Feng
    Wu, Yunjie
    Liu, Yuanzhi
    Zhao, Xiu
    Lei, Jian
    Yang, Shengyong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 92
  • [27] Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors
    Moon, Patrick
    Zammit, Charlotte M.
    Shao, Qian
    Dovala, Dustin
    Boike, Lydia
    Henning, Nathaniel J.
    Knapp, Mark
    Spradlin, Jessica N.
    Ward, Carl C.
    Wolleb, Helene
    Fuller, Daniel
    Blake, Gabrielle
    Murphy, Jason P.
    Wang, Feng
    Lu, Yipin
    Moquin, Stephanie A.
    Tandeske, Laura
    Hesse, Matthew J.
    McKenna, Jeffrey M.
    Tallarico, John A.
    Schirle, Markus
    Toste, F. Dean
    Nomura, Daniel K.
    CHEMBIOCHEM, 2023, 24 (11)
  • [28] Repurposing SARS-CoV-2 Main Protease Inhibitors for HIV-1 Protease Inhibition
    Minkkinen, Jacob P.
    Gentile, Lisa
    FASEB JOURNAL, 2022, 36
  • [29] Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
    Ge, Rui
    Shen, Zuyuan
    Yin, Jian
    Chen, Wenhua
    Zhang, Qi
    An, Yulong
    Tang, Dewei
    Satz, Alexander L.
    Su, Wenji
    Kuai, Letian
    SLAS DISCOVERY, 2022, 27 (02) : 79 - 85
  • [30] Discovery and structure-activity relationship studies of novel a-ketoamide derivatives targeting the SARS-CoV-2 main protease
    Huang, Chong
    Zeng, Rui
    Qiao, Jingxin
    Quan, Baoxue
    Luo, Ronghua
    Huang, Qiao
    Guo, Nihong
    Li, Yueyue
    Long, Xinyan
    Ma, Ronggang
    Xia, Anjie
    Fang, Zhen
    Wang, Yifei
    Li, Yueshan
    Zheng, Yongtang
    Li, Linli
    Lei, Jian
    Yang, Shengyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
12345